fluoxetine has been researched along with 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberati, D; Moreau, JL; Mory, R; Pinard, E; Wettstein, JG | 1 |
1 other study(ies) available for fluoxetine and 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline
Article | Year |
---|---|
Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential.
Topics: Aminoquinolines; Animals; Antipsychotic Agents; Binding Sites; Binding, Competitive; Brain Chemistry; Cell Line; Cricetinae; Cricetulus; DNA, Complementary; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Glycine; Glycine Agents; Glycine Plasma Membrane Transport Proteins; Humans; Male; Membranes; Mice; Morphine; Motor Activity; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors | 2010 |